1. De Vita A, Ravenna SE, Covino M, Lanza O, Franceschi F, Crea F, et al. Electrocardiographic findings and clinical outcome in patients with COVID-19 or other acute infectious respiratory diseases. J Clin Med 2020;9(11):3647. Available from: http://dx.doi.org/10.3390/jcm9113647. [
DOI:10.3390/jcm9113647] [
PMID] [
]
2. Arabi M, Heidari Beigvand H, Samimagham H, Salimi N, Kazemi Jahromi M. Upper limb ischemia following COVID-19 infection: A case report. Jundishapur J Microbiol 2022;15(1):e122074. Available from: http://dx.doi.org/10.5812/jjm.122074. [
DOI:10.5812/jjm.122074]
3. Samimagham HR, Hassani Azad M, Arabi M, Ghazizadeh S, Malektojjari A, Hojjatipour M, et al. The effect of remdesivir in patients with severe COVID-19, reporting case series. Shiraz E Med J 2021;23(4):e116995. Available from: http://dx.doi.org/10.5812/semj.116995. [
DOI:10.5812/semj.116995]
4. Rahimi A, Samimagham HR, Azad MH, Hooshyar D, Arabi M, KazemiJahromi M. The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial. Trials 2021;22(1):271. Available from: http://dx.doi.org/10.1186/s13063-021-05242-4. [
DOI:10.1186/s13063-021-05242-4] [
PMID] [
]
5. Hasani Azad M, Khorrami F, Kazemi Jahromi M, Alishan Karami N, Shahi M, Davari Dolatabadi N, et al. Clinical and epidemiological characteristics of hospitalized COVID-19 patients in Hormozgan, Iran: A retrospective, multicenter study. Arch Iran Med 2021;24(5):434-44. Available from: http://dx.doi.org/10.34172/aim.2021.62. [
DOI:10.34172/aim.2021.62] [
PMID]
6. Samimagham HR, Hassani Azad M, Hooshyar D, Arabi M, Reza Hosseini Z, Kazemi Jahromi M. Adverse effects of Gam-COVID-vac (sputnik V) vaccine. Shiraz E Med J 2021;22(12):e116278. Available from: http://dx.doi.org/10.5812/semj.116278. [
DOI:10.5812/semj.116278]
7. Samimagham HR, Arabi M, Hooshyar D, KazemiJahromi M. The association of non-steroidal anti-inflammatory drugs with COVID-19 severity and mortality. Arch Clin Infect Dis 2020;15(4):e106847. Available from: http://dx.doi.org/10.5812/archcid.106847. [
DOI:10.5812/archcid.106847]
8. Rahimi A, Samimagham HR, Azad MH, Hooshyar D, Arabi M, KazemiJahromi M. The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial. Trials 2021;22(1):271. Available from: http://dx.doi.org/10.1186/s13063-021-05242-4. [
DOI:10.1186/s13063-021-05242-4] [
PMID] [
]
9. Moey MYY, Sengodan PM, Shah N, McCallen JD, Eboh O, Nekkanti R, et al. Electrocardiographic changes and arrhythmias in hospitalized patients with COVID-19. Circ Arrhythm Electrophysiol 2020;13(10):e009023. Available from: http://dx.doi.org/10.1161/CIRCEP.120.009023. [
DOI:10.1161/CIRCEP.120.009023] [
PMID] [
]
10. Samimagham HR, Jahromi MK, Jahromi LK. COVID-19 with Pneumomediastinum and Emphysema, A Case Report. Shiraz E-Med J 2020;21(12):e109424. [
DOI:10.5812/semj.109424]
11. Samimagham HR, Seddighi K, Daryanavard A, Kazemi Jahromi M. Recurrence of COVID-19 Infection. Shiraz E Med J 2020;22(8):e110656. Available from: http://dx.doi.org/10.5812/semj.110656. [
DOI:10.5812/semj.110656]
12. Bertini M, Ferrari R, Guardigli G, Malagù M, Vitali F, Zucchetti O, et al. Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: an insight into the mechanisms of cardiac involvement. Europace 2020;22(12):1848-54. Available from: http://dx.doi.org/10.1093/europace/euaa258. [
DOI:10.1093/europace/euaa258] [
PMID] [
]
13. Ahmadi I, Estabraghnia Babaki H, Maleki M, Jarineshin H, Kaffashian MR, Hassaniazad M, et al. Changes in physiological levels of cortisol and adrenocorticotropic hormone upon hospitalization can predict SARS-CoV-2 mortality: A cohort study. Int J Endocrinol 2022;2022:4280691. Available from: http://dx.doi.org/10.1155/2022/4280691. [
DOI:10.1155/2022/4280691] [
PMID] [
]
14. Cortisone injection [Internet]. MedicineNet. [cited 2022 Sep 3]. Available from: https://www.medicinenet.com/cortisone_injection/article.htm. [
URL]
15. Kapugi, M. and K. Cunningham, Corticosteroids. Orthop Nurs 2019;38(5):336-9. [
DOI:10.1097/NOR.0000000000000595] [
PMID]
16. Guarnotta V, Ferrigno R, Martino M, Barbot M, Isidori AM, Scaroni C, et al. Glucocorticoid excess and COVID-19 disease. Rev Endocr Metab Disord 2021;22(4):703-14. Available from: http://dx.doi.org/10.1007/s11154-020-09598-x. [
DOI:10.1007/s11154-020-09598-x] [
PMID] [
]
17. Dhasmana DJ. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021;384(8):693-704. Available from: http://dx.doi.org/10.1056/NEJMoa2021436. [
DOI:10.1056/NEJMoa2021436] [
PMID] [
]
18. Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 1984 Winter;5(1):25-44. Available from: http://dx.doi.org/10.1210/edrv-5-1-25. [
DOI:10.1210/edrv-5-1-25] [
PMID]
19. Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y, et al. Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. Natl Sci Rev 2020;7(6):998-1002. Available from: http://dx.doi.org/10.1093/nsr/nwaa041. [
DOI:10.1093/nsr/nwaa041] [
PMID] [
]
20. Qi J, He D, Yang D, Wang M, Ma W, Cui H, et al. Severity-associated markers and assessment model for predicting the severity of COVID-19: a retrospective study in Hangzhou, China. BMC Infect Dis 2021;21(1):774. Available from: http://dx.doi.org/10.1186/s12879-021-06509-6. [
DOI:10.1186/s12879-021-06509-6] [
PMID] [
]
21. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8(4):420-2. Available from: http://dx.doi.org/10.1016/S2213-2600(20)30076-X. [
DOI:10.1016/S2213-2600(20)30076-X] [
PMID]
22. Quispe-Laime AM, Bracco JD, Barberio PA, Campagne CG, Rolfo VE, Umberger R, et al. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intensive Care Med 2010;36(1):33-41. Available from: http://dx.doi.org/10.1007/s00134-009-1727-6. [
DOI:10.1007/s00134-009-1727-6] [
PMID] [
]
23. Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC, et al. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: The CoDEX randomized clinical trial: The CoDEX randomized clinical trial. JAMA 2020;324(13):1307-16. Available from: http://dx.doi.org/10.1001/jama.2020.17021. [
DOI:10.1001/jama.2020.17021] [
PMID] [
]
24. Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends 2020;14(1):69-71. [
DOI:10.5582/bst.2020.01020] [
PMID]
25. Arabi YM, Mandourah Y, Al-Hameed F, Sindi AA, Almekhlafi GA, Hussein MA, et al. Corticosteroid therapy for critically ill patients with Middle East Respiratory Syndrome. Am J Respir Crit Care Med 2018;197(6):757-67. Available from: http://dx.doi.org/10.1164/rccm.201706-1172OC. [
DOI:10.1164/rccm.201706-1172OC] [
PMID]
26. Nasiri S, Vafai-manesh J, Adeli SH, Bagherzade M, Tabraii R. Investigating the effect of dexamethasone in patients with corona and hypoxia. Iran J Anesthesiol Spec Care 02021;2(113):20-8. [
URL]
27. Corticosteroids for COVID-19.Who.int. World Health Organization; 2020 [cited 2022 Sep 3]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Corticosteroids-2020.1. [
URL]
28. Tlayjeh H, Mhish OH, Enani MA, Alruwaili A, Tleyjeh R, Thalib L, et al. Association of corticosteroids use and outcomes in COVID-19 patients: A systematic review and meta-analysis. J Infect Public Health 2020;13(11):1652-63. Available from: http://dx.doi.org/10.1016/j.jiph.2020.09.008. [
DOI:10.1016/j.jiph.2020.09.008] [
PMID] [
]
29. Lee KY, Rhim JW, Kang JH. Early preemptive immunomodulators (corticosteroids) for severe pneumonia patients infected with SARS-CoV-2. Clin Exp Pediatr 2020;63(4):117-8. Available from: http://dx.doi.org/10.3345/cep.2020.00290. [
DOI:10.3345/cep.2020.00290] [
PMID] [
]
30. Yang Z, Liu J, Zhou Y, Zhao X, Zhao Q, Liu J. The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis. J Infect 2020;81(1):e13-20. Available from: http://dx.doi.org/10.1016/j.jinf.2020.03.062. [
DOI:10.1016/j.jinf.2020.03.062] [
PMID] [
]
31. Angus DC, Derde L, Al-Beidh F, Annane D, Arabi Y, Beane A, et al. Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: The REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial: The REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial. JAMA 2020;324(13):1317-29. Available from: http://dx.doi.org/10.1001/jama.2020.17022. [
DOI:10.1001/jama.2020.17022] [
PMID] [
]